Zybio Inc.

Zybio Inc. Follow us to know more about our 8 product lines!

Zybio is dedicated to R&D, manufacture, sales and services of laboratory diagnostic devices, including Hematology, Urinalysis, Coagulation, Chemistry, CLIA, POCT, Molecular, Microbiology, etc. Zybio inc., established since 2008 and based in Chongqing China, is a high tech company specializing in the R&D, manufacture, sales, and service of IVD instruments and reagents.

11/06/2026

What makes EXI 1820 not just fast, but exceptionally precise?
✔️Streptavidin(SA)-biotin technology – high affinity binding boosts sensitivity while lowering background signal
✔️Enhanced AMPPD + substrate preheating – shorter incubation time, faster results, and better precision
✔️24/7 uninterrupted refrigerated conditions for reagents tray – reagents stay stable, always ready
✔️Steady incubation temperature control at 37℃ – minimal fluctuations, maximum stability

Speed is nothing without trust. EXI 1820 delivers both.
More details: https://youtu.be/uSPYJMV-tqE

08/06/2026

200 tests/hour. 0.65㎡ footprint. ≤10⁻⁵ carryover. The EXI 1820 doesn't compromise✨
✔50-sample tray capacity
✔Dedicated STAT port – results in 30 seconds
✔Works across Zybio’s platforms for diverse healthcare needs
Curious about more details such as its portfolio? Click to know more: https://youtu.be/uSPYJMV-tqE

26/05/2026

How is Q8 Pro, with footprint less than 0.2㎡, designed for point-of-care testing? Covering a wide portfolio including inflammation, cardiac markers, thyroid markers, etc., it supports multiple sample types such as serum, plasma, whole blood, capillary blood and urine sample. Real-time monitoring of the test disk is enabled on the 15-inch touch screen to check the testing progress. Beneath the testing disk is the constant temperature incubation, ensuring the accuracy of detection results.
More details: https://youtu.be/zUPB8uPmzEw

22/05/2026

How much can Zybio's Q8 Pro analyzer help faster diagnostics? With 25-channel disk detecting various items simultaneously, it enables 120 tests/hour and delivers on-site report in 10 minutes. The first result takes 3-15 minutes, covering a comprehensive portfolio including inflammation, thyroid markers, cardiac markers, diabetes markers, etc.
More details: https://youtu.be/zUPB8uPmzEw

19/05/2026

Third Zybio Asia-Pacific Mass Spectrometry Academic Conference – Wrapped Up in Bali!🥂

On May 12, 2026, we successfully hosted the third edition of our APAC mass spectrometry event in Bali, bringing together 100+ clinical microbiology and laboratory medicine experts from Indonesia, Thailand, Malaysia, Vietnam, and beyond. Under the theme "Precision Mass Spectrometry, Revolutionary Microbial Insight," the conference featured:
✅ Expert-led sessions on MALDI-TOF applications in antimicrobial stewardship
✅ Hands-on workshops for real-world lab training
✅ Panel discussions on direct sample identification and multi-omics innovation

We were privileged to learn from four distinguished speakers: visionary association leader Prof. Dr. Anis Karuniawati, hands-on hospital implementer Dr. Luh Inta Prilandari, innovative Zybio scientist Dr. RD1277, and translational research expert Assoc. Prof. Dr. Pitak Santanirand, and moderators Asst. Prof. Dr. Mingkwan Yingkajorn and Dr. I Wayan Agus Gede Manik Saputra.

A huge thank you to our hosts – the Indonesian Ministry of Health and PAMKI – as well as co-host Genecraft, and to all speakers, partners, and participants for making this a truly impactful gathering.

At Zybio, we remain committed to advancing mass spectrometry technology and fostering regional collaboration to transform pathogen diagnosis and infection control across Asia-Pacific. Let's keep driving precision diagnostics forward – together. 🚀

18/05/2026

How does Zybio's EXR 110 help rapid diagnostics in various scenarios? With comprehensive diagnostic items for cardiac diseases, inflammation, diabetes, etc., rapid results are delivered in 3-15 minutes with this 3.2kg analyzer. It is an ideal choice for rapid testing in ambulance, emergency department, ICU, pediatrics, chest pain center, primary care facilities and other scenarios.
More details: https://youtu.be/Fx7Q6upyHfo

15/05/2026

What makes Zybio's EXR Series POCT analyzer convenient to use
· Rapid results in 3-15 min with 3 channels for different items
· Traceability to international reference materials ensures more reliable results
· Compact and portable design for more flexible usage scenarios
More details: https://youtu.be/Fx7Q6upyHfo

During ESCMID 2026, 3 abstract posters were successfully accepted by ESCMID and showcased during the congress. One of th...
29/04/2026

During ESCMID 2026, 3 abstract posters were successfully accepted by ESCMID and showcased during the congress. One of the studies, about EXP-160R accelerating molecular diagnostics, verified that it achieves rapid thermal cycling through advanced temperature control, detecting 16 samples in 22 minutes with a throughput of 2,400 tests/day. Validation confirmed a detection limit of 200 copies/mL, 100% detection for medium/high viral loads, and clinical sensitivity of 98.05%, specificity of 100%, and accuracy of 99.2% vs. standard diagnostics. Ideal for urgent settings like airports and fever clinics, this innovation sets a new benchmark for rapid, high‑throughput respiratory infection testing.

During ESCMID 2026, 3 abstract posters were successfully accepted by ESCMID and showcased during the congress. One of th...
27/04/2026

During ESCMID 2026, 3 abstract posters were successfully accepted by ESCMID and showcased during the congress. One of the studies is about myxovirus resistance protein A (MxA), a highly specific biomarker for acute viral infections. It effectively distinguishs viral infections from bacterial infections to help curb antibotic overuse. To promote its precise application, this study establishes age-specific MxA reference intervals in apparently healthy children aged 15 days to 18 years (n=255). By accounting for age-related baseline variations, these refined intervals prevent misinterpretation and support accurate antiviral treatment decisions in pediatric clinical practice.

During ESCMID 2026, 3 abstract posters were successfully accepted by ESCMID and showcased during the congress. One of th...
24/04/2026

During ESCMID 2026, 3 abstract posters were successfully accepted by ESCMID and showcased during the congress. One of the studies, of MALDI-TOF MS genome-based database strategy, verified that the technology overcomes conventional database limitations by constructing predicted protein databases from whole genome sequencing data, covering >13,000 species and 174,000 genomes. Validation on 16,091 spectra (250 genera, 731 species) achieved a detection rate of 87.6%, with species-level accuracy of 85.1% and genus-level accuracy of 98.8%. The method also validates conventional database results, enhancing identification credibility without extra time and costs. This marks a significant breakthrough in clinical microbiology for bacterial identification.

Address

Floor 1 To Floor 5, Building 30, No. 6 Of Taikang Road, Block C Of Jianqiao Industrial Park, Dadukou District
Chongqing
400082

Telephone

+86 (0)23 6860 2735

Website

Alerts

Be the first to know and let us send you an email when Zybio Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Zybio Inc.:

Shortcuts

Share